EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rate

Anna N H Walstra, Harriet L Lancaster, Marjolein A Heuvelmans, Carlijn M van der Aalst, Juul Hubert, Dana Moldovanu, Sytse F Oudkerk, Daiwei Han, Jan Willem C Gratama, Mario Silva, Harry J de Koning, Matthijs Oudkerk

European Journal of Cancer · 2025-02 · 216 · 115214

DOI: 10.1016/j.ejca.2024.115214 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025-02. Verfasst von Anna N H Walstra und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Diagnostic Accuracy, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer, Referral and Consultation, Tomography, X-Ray Computed. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme, EU Framework Programme for Research and Innovation Societal Challenges.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsEarly Detection of CancerReferral and ConsultationTomography, X-Ray ComputedArtificial IntelligenceHumansFeasibility StudiesMaleFemaleMiddle AgedAged

Stichwörter der Autor:innen

Artificial Intelligence*ClinicalEarly Detection of CancerFollow-Up StudiesHumansLungMass ScreeningRadiologists*Referral and ConsultationSolitary Pulmonary Nodule / diagnostic imaging*Tomography, X-Ray Computed*Workload

Autor:innen und Institutionen

  • Institute for Diagnostic Accuracy, Groningen, the Netherlands.
  • Institute for Diagnostic Accuracy, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands.
  • Institute for Diagnostic Accuracy, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands; Department of Respiratory Medicine, Am…
  • Department of Public Health, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Radiology Department, Link2Care Clinics, Bilthoven, the Netherlands.
  • Department of Radiology and Nuclear Medicine, Gelre Ziekenhuizen, Apeldoorn, the Netherlands.

Förderung

  • Horizon 2020 Framework Programme
  • EU Framework Programme for Research and Innovation Societal Challenges

Zitieren

APA

Walstra, A. N. H., Lancaster, H. L., Heuvelmans, M. A., van der Aalst, C. M., Hubert, J., Moldovanu, D., Oudkerk, S. F., Han, D., Gratama, J. W. C., Silva, M., de Koning, H. J., & Oudkerk, M. (2025). Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rate. European Journal of Cancer, 216, 115214. https://doi.org/10.1016/j.ejca.2024.115214

Vancouver

Walstra ANH, Lancaster HL, Heuvelmans MA, van der Aalst CM, Hubert J, Moldovanu D, et al. Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rate. European Journal of Cancer. 2025;216:115214. doi:10.1016/j.ejca.2024.115214

BibTeX
@article{Walstra2025,
  author = {Walstra, Anna N H and Lancaster, Harriet L and Heuvelmans, Marjolein A and van der Aalst, Carlijn M and Hubert, Juul and Moldovanu, Dana and Oudkerk, Sytse F and Han, Daiwei and Gratama, Jan Willem C and Silva, Mario and de Koning, Harry J and Oudkerk, Matthijs},
  title = {Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rate},
  journal = {European Journal of Cancer},
  year = {2025},
  volume = {216},
  pages = {115214},
  doi = {10.1016/j.ejca.2024.115214}
}
Kostenlos starten →